Loading...
Leveraging human genetics to identify safety signals prior to drug marketing approval and clinical use
INTRODUCTION: When a new drug or biologic product enters the market, its full spectrum of side effects is not yet fully understood, as use in the real world often uncovers nuances not suggested within the relatively narrow confines of preapproval preclinical and trial work. OBJECTIVE: We describe a...
Na minha lista:
| Udgivet i: | Drug Saf |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7398579/ https://ncbi.nlm.nih.gov/pubmed/32112228 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-020-00915-6 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|